ASCELIA PHARMA IS AN ONCOLOGY-DEDICATED DRUG DEVELOPMENT COMPANY

Product pipeline

Lead candidate Mangoral (phase III ready) is an MRI imaging drug being developed for detection and localization of liver metastases.

Oncoral (phase II ready) is a novel tablet-based irinotecan formulation, intended for treatment of advanced gastric (stomach) cancer.

Events

There are no upcoming events at this time.